Redcare Pharmacy, NL0012044747

Redcare Pharmacy stock at EUR 68.20 on September 28, 2026, up 12.73 percent

Published on 09/28/2026 at 18:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Redcare Pharmacy shares last traded at EUR 68.20 in Frankfurt on September 28, 2026, up 12.73 percent. The company raised its 2026 revenue growth guidance to 16 percent to 18 percent.

Flatlay mit Aktienzertifikat, ISIN-Karte, Pillenblistern und Stethoskop von oben
Redcare Pharmacy (Shop Apoth), ISIN NL0012044747, zeigt Flatlay mit Aktienzertifikat, ISIN-Karte und markenfreien Apotheken-Utensilien, Illustration mit AI erstellt.

Redcare Pharmacy shares last traded at EUR 68.20 on Frankfurt’s primary listing on September 28, 2026, at 15:35 UTC. The stock was up EUR 7.70, or 12.73 percent, from the previous close.

2026 guidance raised again

Redcare Pharmacy N.V. said in an EQS announcement dated September 28 that it had raised its full-year 2026 revenue growth guidance to 16 percent to 18 percent. The company said this was the second guidance increase of the year and cited continued momentum in prescription, or Rx, revenue in Germany.

The company now expects German Rx revenue of EUR 730 million to EUR 760 million for full-year 2026. Its adjusted EBITDA margin guidance remains between 2.5 percent and 3.0 percent, according to the same announcement.

Upcoming reporting date

Redcare Pharmacy said it will publish its interim statement for the third quarter of 2026 and hold its quarterly conference call on October 29, 2026, according to the EQS release.

Digital prescription service extended

Separately, Redcare Pharmacy’s investor-relations newsroom reported that gematik extended approval for CardLink until March 31, 2028. The extension allows Shop Apotheke customers in Germany to continue redeeming e-prescriptions digitally through the app, according to the company’s September 15 announcement.

Disclaimer...

en | NL0012044747 | REDCARE PHARMACY | boerse | 70193908 | bgmi